Cel-Sci Corp. (CVM)

Cel-Sci (CVM) Stock Price & Analysis


CVM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.08 - $3.68
Previous Close$1.21
Average Volume (3M)344.47K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$5.14M
Total Debt (Recent Filing)$14.02M
Price to Earnings (P/E)-1.6
Dec 20, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.77
Shares Outstanding47,260,097
10 Day Avg. Volume181,330
30 Day Avg. Volume344,467
Standard Deviation0.32
Financial Highlights & Ratios
Price to Book (P/B)3.85
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Cel-Sci Corp.’s price range in the past 12 months?
Cel-Sci Corp. lowest stock price was $1.08 and its highest was $3.68 in the past 12 months.
    What is Cel-Sci Corp.’s market cap?
    Currently, no data Available
    When is Cel-Sci Corp.’s upcoming earnings report date?
    Cel-Sci Corp.’s upcoming earnings report date is Dec 20, 2023 which is in 81 days.
      How were Cel-Sci Corp.’s earnings last quarter?
      Cel-Sci Corp. released its earnings results on Aug 11, 2023. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.15 by -$0.42.
        Is Cel-Sci Corp. overvalued?
        According to Wall Street analysts Cel-Sci Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Cel-Sci Corp. pay dividends?
          Cel-Sci Corp. does not currently pay dividends.
          What is Cel-Sci Corp.’s EPS estimate?
          Cel-Sci Corp.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Cel-Sci Corp. have?
          Cel-Sci Corp. has 47,260,098 shares outstanding.
            What happened to Cel-Sci Corp.’s price movement after its last earnings report?
            Cel-Sci Corp. reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.15. Following the earnings report the stock price went down -12.676%.
              Which hedge fund is a major shareholder of Cel-Sci Corp.?
              Among the largest hedge funds holding Cel-Sci Corp.’s share is Perceptive Advisors LLC. It holds Cel-Sci Corp.’s shares valued at N/A.


                Cel-Sci Stock Smart Score

                The Cel-Sci stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Cel-Sci Corp.

                CEL-SCI Corp. is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients; and CEL-2000 and CEL-4000 which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.


                Top 5 ETFs holding CVM

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                iShares Core S&P Total U.S. Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold CVM. The ETFs are listed according to market value of CVM within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Aethlon Medical
                Cellectar Biosciences
                Cyclacel Pharmaceuticals
                Infinity Pharma

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis